BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fleischmann A, Schlomm T, Köllermann J, Sekulic N, Huland H, Mirlacher M, Sauter G, Simon R, Erbersdobler A. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate 2009;69:976-81. [PMID: 19274666 DOI: 10.1002/pros.20948] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Solimando AG, Desantis V, Ribatti D. Mast Cells and Interleukins. Int J Mol Sci 2022;23. [PMID: 36430483 DOI: 10.3390/ijms232214004] [Reference Citation Analysis]
2 Brockmeyer P, Hemmerlein B. Mast cell-tumor cell interactions via extracellular vesicles: A minireview. TEV 2022;4:34-38. [DOI: 10.47184/tev.2022.01.04] [Reference Citation Analysis]
3 Li F, Cai J, Liu J, Yu S, Zhang X, Su Y, Gao L. Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis. Front Oncol 2022;12:925615. [DOI: 10.3389/fonc.2022.925615] [Reference Citation Analysis]
4 Xu C, Liu Z, Yan C, Xiao J. Application of apoptosis-related genes in a multiomics-related prognostic model study of gastric cancer. Front Genet 2022;13:901200. [DOI: 10.3389/fgene.2022.901200] [Reference Citation Analysis]
5 Shan L, Lu Y, Song Y, Zhu X, Xiang C, Zuo E, Cheng X, Li T. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/9529814] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zhao D, Zhang Z, Wang Z, Du Z, Wu M, Zhang T, Zhou J, Zhao W, Meng Y. Diagnosis and Prediction of Endometrial Carcinoma Using Machine Learning and Artificial Neural Networks Based on Public Databases. Genes (Basel) 2022;13:935. [PMID: 35741697 DOI: 10.3390/genes13060935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shan L, Lu Y, Xiang C, Zhu X, Zuo E, Cheng X, Wang F. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/2547029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li L, Tao Z, Zhao Y, Li M, Zheng J, Li Z, Chen X. Prognostic Characteristics and Immune Effects of N6-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma. Front Genet 2022;13:864383. [DOI: 10.3389/fgene.2022.864383] [Reference Citation Analysis]
9 Fereydouni M, Motaghed M, Ahani E, Kafri T, Dellinger K, Metcalfe DD, Kepley CL. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. Front Oncol 2022;12:830199. [DOI: 10.3389/fonc.2022.830199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Peña-romero AC, Orenes-piñero E. Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. Cancers 2022;14:1681. [DOI: 10.3390/cancers14071681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Sobiepanek A, Kuryk Ł, Garofalo M, Kumar S, Baran J, Musolf P, Siebenhaar F, Fluhr JW, Kobiela T, Plasenzotti R, Kuchler K, Staniszewska M. The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers. IJMS 2022;23:2249. [DOI: 10.3390/ijms23042249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Segura-villalobos D, Ramírez-moreno IG, Martínez-aguilar M, Ibarra-sánchez A, Muñoz-bello JO, Anaya-rubio I, Padilla A, Macías-silva M, Lizano M, González-espinosa C. Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth. Cells 2022;11:349. [DOI: 10.3390/cells11030349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Das B, Mendonca S. Prognostic significance of mast cells and vascular density in prostatic adenocarcinoma. Indian J Pathol Microbiol 2022;0:0. [DOI: 10.4103/ijpm.ijpm_93_21] [Reference Citation Analysis]
14 Noto CN, Hoft SG, DiPaolo RJ. Mast Cells as Important Regulators in Autoimmunity and Cancer Development. Front Cell Dev Biol 2021;9:752350. [PMID: 34712668 DOI: 10.3389/fcell.2021.752350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li H, Mo Z. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Int J Gen Med 2021;14:6885-98. [PMID: 34703293 DOI: 10.2147/IJGM.S328109] [Reference Citation Analysis]
16 Tang Q, Cheng B, Dai R, Wang R. The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells. Front Cell Dev Biol 2021;9:729498. [PMID: 34692685 DOI: 10.3389/fcell.2021.729498] [Reference Citation Analysis]
17 Sfanos KS. Immune cell infiltrates and prognosis in localized prostate cancer. J Pathol 2021. [PMID: 34694014 DOI: 10.1002/path.5817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li F, Cai J, Liu J, Yu S, Zhang X, Su Y, Gao L. Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis.. [DOI: 10.1101/2021.09.15.460430] [Reference Citation Analysis]
19 Meng L, Ma R, Yan R, Yuan D, Li Y, Shi L, Li K. Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma. J Gastrointest Oncol 2021;12:1152-63. [PMID: 34295564 DOI: 10.21037/jgo-21-291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Taborska P, Stakheev D, Bartunkova J, Smrz D. Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy. Int J Mol Sci 2021;22:3978. [PMID: 33921475 DOI: 10.3390/ijms22083978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Teng LKH, Pereira BA, Keerthikumar S, Huang C, Niranjan B, Lee SN, Richards M, Schittenhelm RB, Furic L, Goode DL, Lawrence MG, Taylor RA, Ellem SJ, Risbridger GP, Lister NL. Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment. Cancers (Basel) 2021;13:1237. [PMID: 33799802 DOI: 10.3390/cancers13061237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hempel Sullivan H, Maynard JP, Heaphy CM, Lu J, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes. J Pathol 2021;253:415-26. [PMID: 33338262 DOI: 10.1002/path.5606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Domagala M, Laplagne C, Leveque E, Laurent C, Fournié JJ, Espinosa E, Poupot M. Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells. Cancers (Basel) 2021;13:E165. [PMID: 33418996 DOI: 10.3390/cancers13020165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
24 Yao J, Xi W, Chen X, Xiong Y, Zhu Y, Wang H, Hu X, Guo J. Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour-infiltrating lymphocytes. Scand J Immunol 2021;93:e13006. [PMID: 33275792 DOI: 10.1111/sji.13006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 2020;20:662-80. [PMID: 32753728 DOI: 10.1038/s41568-020-0285-7] [Cited by in Crossref: 370] [Cited by in F6Publishing: 404] [Article Influence: 123.3] [Reference Citation Analysis]
26 Sullivan HH, Maynard JP, Heaphy CM, Lu J, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. Differential Mast Cell Phenotypes in Benign versus Cancer Tissues and Prostate Cancer Oncologic Outcomes.. [DOI: 10.1101/2020.07.23.216408] [Reference Citation Analysis]
27 Pan Q, Wang L, Chai S, Zhang H, Li B. The immune infiltration in clear cell Renal Cell Carcinoma and their clinical implications: A study based on TCGA and GEO databases. J Cancer 2020;11:3207-15. [PMID: 32231726 DOI: 10.7150/jca.37285] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
28 Ávila-rodríguez D, Segura-villalobos DL, Ibarra-sánchez A, González-espinosa C, Macías-silva M. TGF-β y células cebadas: reguladores del desarrollo del tumor. TIP RECQB 2020;23. [DOI: 10.22201/fesz.23958723e.2020.0.200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Aponte-López A, Muñoz-Cruz S. Mast Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1273:159-73. [PMID: 33119881 DOI: 10.1007/978-3-030-49270-0_9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
30 Schneider G. S1P Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2020;1223:129-53. [PMID: 32030688 DOI: 10.1007/978-3-030-35582-1_7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
31 Büscheck F, Sulimankhil M, Melling N, Höflmayer D, Hube-Magg C, Simon R, Göbel C, Hinsch A, Weidemann S, Izbicki JR, Jacobsen F, Mandelkow T, Blessin NC, Möller-Koop C, Lutz F, Viehweger F, Möller K, Sauter G, Lennartz M, Burandt E, Lebok P, Minner S, Bonk S, Huland H, Graefen M, Schlomm T, Fraune C. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients. Cancer Med 2020;9:1409-18. [PMID: 31893572 DOI: 10.1002/cam4.2773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Tharp D, Nandana S. How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis. Cancers (Basel) 2019;11:E1928. [PMID: 31817000 DOI: 10.3390/cancers11121928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Hayashi T, Fujita K, Matsushita M, Nonomura N. Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer. Cancers (Basel). 2019;11:1153. [PMID: 31408948 DOI: 10.3390/cancers11081153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
34 Sammarco G, Varricchi G, Ferraro V, Ammendola M, De Fazio M, Altomare DF, Luposella M, Maltese L, Currò G, Marone G, Ranieri G, Memeo R. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Int J Mol Sci 2019;20:E2106. [PMID: 31035644 DOI: 10.3390/ijms20092106] [Cited by in Crossref: 86] [Cited by in F6Publishing: 96] [Article Influence: 21.5] [Reference Citation Analysis]
35 Derakhshani A, Vahidian F, Alihasanzadeh M, Mokhtarzadeh A, Lotfi Nezhad P, Baradaran B. Mast cells: A double-edged sword in cancer. Immunol Lett 2019;209:28-35. [PMID: 30905824 DOI: 10.1016/j.imlet.2019.03.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
36 Xu W, Qian J, Zeng F, Li S, Guo W, Chen L, Li G, Zhang Z, Wang QJ, Deng F. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment. J Exp Clin Cancer Res 2019;38:114. [PMID: 30841931 DOI: 10.1186/s13046-019-1118-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
37 Pereira BA, Lister NL, Hashimoto K, Teng L, Flandes-iparraguirre M, Eder A, Sanchez-herrero A, Niranjan B, Frydenberg M, Papargiris MM, Lawrence MG, Taylor RA, Hutmacher DW, Ellem SJ, Risbridger GP, De-juan-pardo EM. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro. Biomaterials 2019;197:72-85. [DOI: 10.1016/j.biomaterials.2018.12.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
38 Defourny SVP, Romanucci M, Grieco V, Quaglione GR, Santolini C, Della Salda L. Tumor⁻Microenvironment Interaction: Analysis of Mast Cell Populations in Normal Tissue and Proliferative Disorders of the Canine Prostate. Vet Sci 2019;6:E16. [PMID: 30781786 DOI: 10.3390/vetsci6010016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Varricchi G, Raap U, Rivellese F, Marone G, Gibbs BF. Human mast cells and basophils-How are they similar how are they different? Immunol Rev 2018;282:8-34. [PMID: 29431214 DOI: 10.1111/imr.12627] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 20.3] [Reference Citation Analysis]
40 Ribatti D. Mast Cells in Tumor Angiogenesis and Lymphangiogenesis. The Mast Cell 2019. [DOI: 10.1007/978-3-030-24190-2_11] [Reference Citation Analysis]
41 Ribatti D, Tamma R, Crivellato E. The dual role of mast cells in tumor fate. Cancer Lett 2018;433:252-8. [PMID: 29981810 DOI: 10.1016/j.canlet.2018.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
42 Meyer N, Zenclussen AC. Mast cells-Good guys with a bad image? Am J Reprod Immunol 2018;80:e13002. [DOI: 10.1111/aji.13002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
43 Burdelski C, Borcherding L, Kluth M, Hube-Magg C, Melling N, Simon R, Möller-Koop C, Weigand P, Minner S, Haese A, Michl HU, Tsourlakis MC, Jacobsen F, Hinsch A, Wittmer C, Lebok P, Steurer S, Izbicki JR, Sauter G, Krech T, Büscheck F, Clauditz T, Schlomm T, Wilczak W. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer. Oncotarget 2017;8:31494-508. [PMID: 28415558 DOI: 10.18632/oncotarget.16357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Vlajnic T, Eppenberger-Castori S, Bubendorf L. Protocols for Tissue Microarrays in Prostate Cancer Studies. Methods Mol Biol 2018;1786:103-16. [PMID: 29786789 DOI: 10.1007/978-1-4939-7845-8_6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Inflammation and Prostate Cancer. Adv Exp Med Biol 2018;1095:41-65. [PMID: 30229548 DOI: 10.1007/978-3-319-95693-0_3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
46 Cozzo AJ, Fuller AM, Makowski L. Contribution of Adipose Tissue to Development of Cancer. Compr Physiol 2017;8:237-82. [PMID: 29357128 DOI: 10.1002/cphy.c170008] [Cited by in Crossref: 103] [Cited by in F6Publishing: 111] [Article Influence: 17.2] [Reference Citation Analysis]
47 Brockmeyer P, Kling A, Schulz X, Perske C, Schliephake H, Hemmerlein B. High mast cell density indicates a longer overall survival in oral squamous cell carcinoma. Sci Rep 2017;7:14677. [PMID: 29116177 DOI: 10.1038/s41598-017-15406-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
48 Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D. Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer. Oncotarget 2017;8:82583-92. [PMID: 29137286 DOI: 10.18632/oncotarget.19773] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
49 Foroozan M, Roudi R, Abolhasani M, Gheytanchi E, Mehrazma M. Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinoma. Pathol Res Pract 2017;213:612-8. [PMID: 28552539 DOI: 10.1016/j.prp.2017.04.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
50 Varricchi G, Galdiero MR, Loffredo S, Marone G, Iannone R, Marone G, Granata F. Are Mast Cells MASTers in Cancer? Front Immunol 2017;8:424. [PMID: 28446910 DOI: 10.3389/fimmu.2017.00424] [Cited by in Crossref: 149] [Cited by in F6Publishing: 174] [Article Influence: 24.8] [Reference Citation Analysis]
51 Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang Z, Xie H, Dai B, Xu J, Ye D. Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma. Ann Surg Oncol 2017;24:1435-42. [PMID: 27896514 DOI: 10.1245/s10434-016-5702-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
52 Hempel HA, Cuka NS, Kulac I, Barber JR, Cornish TC, Platz EA, De Marzo AM, Sfanos KS. Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence. Prostate 2017;77:412-24. [PMID: 27868214 DOI: 10.1002/pros.23280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
53 Varricchi G, Galdiero MR, Marone G, Granata F, Borriello F, Marone G. Controversial role of mast cells in skin cancers. Exp Dermatol 2017;26:11-7. [PMID: 27305467 DOI: 10.1111/exd.13107] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
54 Rodriguez YI, Campos LE, Castro MG, Aladhami A, Oskeritzian CA, Alvarez SE. Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment. Front Oncol 2016;6:218. [PMID: 27800303 DOI: 10.3389/fonc.2016.00218] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
55 Shiao SL, Chu GC, Chung LW. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett 2016;380:340-8. [PMID: 26828013 DOI: 10.1016/j.canlet.2015.12.022] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 16.4] [Reference Citation Analysis]
56 Marshall JS, Portales-cervantes L, Haidl ID. Mast Cells in Allergy, Host Defense, and Immune Regulation. Encyclopedia of Immunobiology 2016. [DOI: 10.1016/b978-0-12-374279-7.03005-8] [Reference Citation Analysis]
57 Joensuu H, Eriksson M, Sundby Hall K, Reichardt A, Hartmann JT, Pink D, Ramadori G, Hohenberger P, Al-Batran SE, Schlemmer M. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. J Clin Oncol. 2016;34:244-250. [PMID: 26527782 DOI: 10.1200/jco.2015.62.9170] [Cited by in Crossref: 126] [Cited by in F6Publishing: 146] [Article Influence: 15.8] [Reference Citation Analysis]
58 Strasner A, Karin M. Immune Infiltration and Prostate Cancer. Front Oncol 2015;5:128. [PMID: 26217583 DOI: 10.3389/fonc.2015.00128] [Cited by in Crossref: 114] [Cited by in F6Publishing: 126] [Article Influence: 14.3] [Reference Citation Analysis]
59 de Souza Junior DA, Santana AC, da Silva EZ, Oliver C, Jamur MC. The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis. Biomed Res Int 2015;2015:142359. [PMID: 26146612 DOI: 10.1155/2015/142359] [Cited by in Crossref: 44] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
60 Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C. Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Mol Oncol 2015;9:1241-51. [PMID: 25817444 DOI: 10.1016/j.molonc.2015.02.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
61 Debruin EJ, Gold M, Lo BC, Snyder K, Cait A, Lasic N, Lopez M, Mcnagny KM, Hughes MR. Mast Cells in Human Health and Disease. Mast Cells 2015. [DOI: 10.1007/978-1-4939-1568-2_7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
62 da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014;62:698-738. [PMID: 25062998 DOI: 10.1369/0022155414545334] [Cited by in Crossref: 342] [Cited by in F6Publishing: 365] [Article Influence: 38.0] [Reference Citation Analysis]
63 Burdelski C, Matuszewska A, Kluth M, Koop C, Grupp K, Steurer S, Wittmer C, Minner S, Tsourlakis MC, Sauter G, Schlomm T, Simon R. Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer. Microarrays (Basel) 2014;3:137-58. [PMID: 27600340 DOI: 10.3390/microarrays3020137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Hartmann A, Schlomm T, Bertz S, Heinzelmann J, Hölters S, Simon R, Stoehr R, Junker K. [Prognostic and predictive molecular markers for urologic cancers]. Urologe A 2014;53:491-500. [PMID: 24700189 DOI: 10.1007/s00120-014-3442-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Oldford SA, Marshall JS. Mast cells as targets for immunotherapy of solid tumors. Mol Immunol 2015;63:113-24. [PMID: 24698842 DOI: 10.1016/j.molimm.2014.02.020] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 12.2] [Reference Citation Analysis]
66 Jaafari-Ashkavandi Z, Ashraf MJ. Increased mast cell counts in benign and malignant salivary gland tumors. J Dent Res Dent Clin Dent Prospects 2014;8:15-20. [PMID: 25024834 DOI: 10.5681/joddd.2014.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Isfoss BL, Busch C, Hermelin H, Vermedal AT, Kile M, Braathen GJ, Majak B, Berner A. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma. Virchows Arch 2014;464:473-88. [PMID: 24570393 DOI: 10.1007/s00428-014-1561-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
68 Colombo MP, Pittoni P. Mast Cells and Immune Response in Cancer. Tumor-Induced Immune Suppression 2014. [DOI: 10.1007/978-1-4899-8056-4_3] [Reference Citation Analysis]
69 Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol 2014;816:153-81. [PMID: 24818723 DOI: 10.1007/978-3-0348-0837-8_7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
70 Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F. Mast cells as a potential prognostic marker in prostate cancer. Dis Markers 2013;35:711-20. [PMID: 24324287 DOI: 10.1155/2013/478303] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
71 Stawerski P, Wagrowska-Danilewicz M, Stasikowska-Kanicka O, Tuka E, Danilewicz M. Augmented mast cell infiltration and microvessel density in prostate cancer. Contemp Oncol (Pozn) 2013;17:378-82. [PMID: 24592126 DOI: 10.5114/wo.2013.37220] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Tsourlakis MC, Walter E, Quaas A, Graefen M, Huland H, Simon R, Sauter G, Steurer S, Schlomm T, Minner S. High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy. Prostate Cancer Prostatic Dis 2013;16:159-64. [DOI: 10.1038/pcan.2012.50] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
73 Flammiger A, Weisbach L, Huland H, Tennstedt P, Simon R, Minner S, Bokemeyer C, Sauter G, Schlomm T, Trepel M. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. Eur J Cancer. 2013;49:1273-1279. [PMID: 23266046 DOI: 10.1016/j.ejca.2012.11.035] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 7.3] [Reference Citation Analysis]
74 Vidal MTA, de Oliveira Araújo IB, Gurgel CAS, Pereira FDAC, Vilas-bôas DS, Ramos EAG, Agra IMG, Barros AC, Freitas VS, dos Santos JN. Density of mast cells and microvessels in minor salivary gland tumors. Tumor Biol 2013;34:309-16. [DOI: 10.1007/s13277-012-0552-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
75 Flammiger A, Bayer F, Cirugeda-Kühnert A, Huland H, Tennstedt P, Simon R, Minner S, Bokemeyer C, Sauter G, Schlomm T, Trepel M. Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer. APMIS 2012;120:901-8. [PMID: 23009114 DOI: 10.1111/j.1600-0463.2012.02924.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
76 Zhang C, Gao D, Zhou G, Chen L, Zhang X, Cui Z, He Z. Label‐Free Homogeneous Immunosensor Based on FRET for the Detection of Virus Antibody in Serum. Chem Asian J 2012;7:1764-7. [DOI: 10.1002/asia.201200221] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
77 Gilfillan AM, Beaven MA. Regulation of mast cell responses in health and disease. Crit Rev Immunol 2011;31:475-529. [PMID: 22321108 DOI: 10.1615/critrevimmunol.v31.i6.30] [Cited by in Crossref: 173] [Cited by in F6Publishing: 180] [Article Influence: 15.7] [Reference Citation Analysis]
78 Simon R, Mirlacher M. Tissue Microarrays for Translational Research. Microarrays in Diagnostics and Biomarker Development 2012. [DOI: 10.1007/978-3-642-28203-4_9] [Reference Citation Analysis]
79 Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D, Elsum I, Greenfield A, Tuveson DA, Simon R, Humbert PO. SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J Clin Invest 2011;121:4257-67. [PMID: 21965329 DOI: 10.1172/JCI58509] [Cited by in Crossref: 135] [Cited by in F6Publishing: 138] [Article Influence: 11.3] [Reference Citation Analysis]
80 Khazaie K, Blatner NR, Khan MW, Gounari F, Gounaris E, Dennis K, Bonertz A, Tsai FN, Strouch MJ, Cheon E, Phillips JD, Beckhove P, Bentrem DJ. The significant role of mast cells in cancer. Cancer Metastasis Rev 2011;30:45-60. [PMID: 21287360 DOI: 10.1007/s10555-011-9286-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 127] [Article Influence: 12.3] [Reference Citation Analysis]
81 Chen L, Zhang X, Zhang C, Zhou G, Zhang W, Xiang D, He Z, Wang H. Dual-Color Fluorescence and Homogeneous Immunoassay for the Determination of Human Enterovirus 71. Anal Chem 2011;83:7316-22. [DOI: 10.1021/ac201129d] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
82 Josefsson A, Adamo H, Hammarsten P, Granfors T, Stattin P, Egevad L, Laurent AE, Wikström P, Bergh A. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. Am J Pathol 2011;179:1961-8. [PMID: 21854754 DOI: 10.1016/j.ajpath.2011.06.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
83 Mendes LO, Amorim JP, Teixeira GR, Chuffa LG, Fioruci BA, Pimentel TA, de Mello W Jr, Padovani CR, Pereira S, Martinez M, Pinheiro PF, Oliani SM, Martinez FE. Mast cells and ethanol consumption: interactions in the prostate, epididymis and testis of UChB rats. Am J Reprod Immunol 2011;66:170-8. [PMID: 21241399 DOI: 10.1111/j.1600-0897.2010.00958.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
84 Ribatti D, Crivellato E. Mast cells, angiogenesis and cancer. Adv Exp Med Biol 2011;716:270-88. [PMID: 21713661 DOI: 10.1007/978-1-4419-9533-9_14] [Cited by in Crossref: 50] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
85 Schlomm T, Chun FKh, Erbersdobler A. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer. Methods Mol Biol 2010;664:177-89. [PMID: 20690063 DOI: 10.1007/978-1-60761-806-5_17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
86 Halin S, Hammarsten P, Adamo H, Wikström P, Bergh A. Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer. Expert Opin Med Diagn 2011;5:37-47. [PMID: 23484475 DOI: 10.1517/17530059.2011.540009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
87 Oldford SA, Haidl ID, Howatt MA, Leiva CA, Johnston B, Marshall JS. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol 2010;185:7067-76. [PMID: 21041732 DOI: 10.4049/jimmunol.1001137] [Cited by in Crossref: 93] [Cited by in F6Publishing: 100] [Article Influence: 7.2] [Reference Citation Analysis]
88 Araújo CP, Gurgel CAS, Ramos EAG, Freitas VS, de Almeida Barbosa Júnior A, Ramalho LMP, dos Santos JN. Accumulation of CD1a-positive Langerhans cells and mast cells in actinic cheilitis. J Mol Hist 2010;41:357-65. [DOI: 10.1007/s10735-010-9297-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
89 Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J, Stattin P, Egevad L, Granfors T, Wikström P, Bergh A. Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol 2010;177:1031-41. [PMID: 20616342 DOI: 10.2353/ajpath.2010.100070] [Cited by in Crossref: 138] [Cited by in F6Publishing: 148] [Article Influence: 10.6] [Reference Citation Analysis]
90 Hägglöf C, Hammarsten P, Josefsson A, Stattin P, Paulsson J, Bergh A, Ostman A. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival. PLoS One 2010;5:e10747. [PMID: 20505768 DOI: 10.1371/journal.pone.0010747] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.8] [Reference Citation Analysis]
91 Bergh A. Characterization and functional role of the stroma compartment in prostate tumors. Future Oncol 2009;5:1231-5. [PMID: 19852737 DOI: 10.2217/fon.09.104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
92 Simon R. Applications of tissue microarray technology. Methods Mol Biol 2010;664:1-16. [PMID: 20690047 DOI: 10.1007/978-1-60761-806-5_1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
93 Sauter G. Representativity of TMA studies. Methods Mol Biol 2010;664:27-35. [PMID: 20690049 DOI: 10.1007/978-1-60761-806-5_3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]